Mycobacterium tuberculosis immunization
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 4, 2006
Grant Date -
N/A
app pub date -
Feb 9, 2000
filing date -
Feb 9, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Recombinant nucleic acid molecules are described. The molecules have a sequence or sequences encoding at least two M. tuberculosis antigens. Vectors and compositions containing these molecules are also described. In addition, compositions containing a cocktail of recombinant nucleic acid molecules having a sequence or sequences encoding one or more M. tuberculosis antigens are described. Methods of eliciting an immune response using these molecules and compositions are also described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully